WuXi Biologics (Cayman) Inc. (HKG:2269)
33.94
+0.24 (0.71%)
Apr 29, 2026, 4:08 PM HKT
WuXi Biologics Market Cap
WuXi Biologics has a market cap or net worth of 139.44 billion as of April 29, 2026. Its market cap has increased by 29.62% in one year.
Market Cap
139.44B
Enterprise Value
131.83B
Revenue
24.25B
Ranking
n/a
PE Ratio
26.09
Stock Price
33.94
Market Cap Chart
Since June 13, 2017, WuXi Biologics's market cap has increased from 32.04B to 139.44B, an increase of 335.23%. That is a compound annual growth rate of 18.01%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Innovent Biologics | 143.33B |
| Akeso | 125.64B |
| Sichuan Kelun-Biotech Biopharmaceutical | 109.41B |
| Sino Biopharmaceutical | 97.87B |
| RemeGen | 76.34B |
| BeOne Medicines AG | 259.78B |
| 3SBio | 55.90B |
| Shanghai Junshi Biosciences | 43.42B |